VERTANICAL

VERTANICAL is a biopharmaceutical company focused on developing and distributing innovative therapies for chronic pain. Its lead product, VER-01, is a cannabinoid-based medication developed through an extensive preclinical and clinical program, initially targeting chronic low back pain. The company’s mission is to establish VER-01 as a leading pain therapy, while addressing associated symptoms such as sleep disorders and depressive moods.